Company
United StatesPublic company, NASDAQ: RAREUltragenyx Pharmaceutical Inc. (NASDAQ: RARE), Bedford, MA – FDA Inspections
Inspection records and compliance data for Ultragenyx Pharmaceutical Inc. in Bedford, MA. 1 FDA inspection on record, 1 Form 483, last inspected April 25, 2025. Publicly traded as NASDAQ: RARE.
Company Profile
This profile covers Ultragenyx Pharmaceutical Inc. based in Bedford, MA, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
Inspected April 25, 2025.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| April 25, 2025 | Not classified | Biologics | 1269681 |
FDA documents
Form 483s (2)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Ultragenyx Pharmaceutical Inc.
Stock ticker
RARE
Exchange
NASDAQ
Share price
$16.27
Market cap
$1.7B
Price as of
November 13, 2026
FEI Number
3025268614
Address
170 Middlesex Tpke, Bedford, MA 01730, United States
Country
United States
ID: eced36f4-f37f-4271-b0fa-cad0b7de872b